Resistant depression and deep brain stimulation (DBS) in SARS-CoV-2 patients
DOI:
https://doi.org/10.35839/repis.7.3.1812Downloads
References
Mazza MG, Palladini M, Villa G, Agnoletto E, Harrington Y, Vai B, et al. Prevalence of depression in SARS-CoV-2 infected patients: An umbrella review of meta-analyses. Gen Hosp Psychiatry. 2023;80:17–25. doi: 10.1016/j.genhosppsych.2022.12.002
Ezquiaga Terrazas E, García López A, Díaz de Neira M, García Barquero MJ. “Depresión”: Imprecisión diagnóstica y terapéutica. Importantes consecuencias en la práctica clínica. Rev Asoc Esp Neuropsiquiatría. 2011;31(3):457–75. doi: 10.4321/S0211-57352011000300005
Papp M, Cubala WJ, Swiecicki L, Newman-Tancredi A, Willner P. Perspectives for therapy of treatment-resistant depression. Br J Pharmacol. 2022 ;179(17):4181–200. doi: 10.1111/bph.15596
Santel M, Beblo T, Neuner F, Berg M, Hennig-Fast K, Jobes DA, et al. Collaborative Assessment and Management of Suicidality (CAMS) compared to enhanced treatment as usual (E-TAU) for suicidal patients in an inpatient setting: study protocol for a randomized controlled trial. BMC Psychiatry. 2020 22;20:183. doi: 10.1186/s12888-020-02589-x
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Adoniram Ramírez-Hernández
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
.png)
